NRP104 40 mg Pill - green & white capsule/oblong, 16mm
Generic Name: lisdexamfetamine
Pill with imprint NRP104 40 mg is Green & White, Capsule/Oblong and has been identified as Vyvanse 40 mg. It is supplied by Shire US Inc.
Vyvanse is used in the treatment of Binge Eating Disorder; ADHD and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Vyvanse 40 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for NRP104 40 mg
Vyvanse
- Generic Name
- lisdexamfetamine
- Imprint
- NRP104 40 mg
- Strength
- 40 mg
- Color
- Green & White
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Shire US Inc.
- National Drug Code (NDC)
- 59417-0104
- Inactive Ingredients
-
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
titanium dioxide,
FD&C Blue No. 1,
ferrosoferric oxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
See also:
Arynta
Arynta is used to treat Attention Deficit Hyperactivity Disorder (ADHD) in adults and children 6 ...
Adderall
Adderall (amphetamine and dextroamphetamine) is used to treat narcolepsy and ADHD. Includes side ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Adipex-P
Adipex-P (phentermine) is an appetite suppressant used togther with diet and exercise to treat ...
More about Vyvanse (lisdexamfetamine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (975)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.